MedPath

Study Evaluating the Effect of Isonatremic Dialysis Treatment in Chronic Kidney Disease Patients on Dialysis

Conditions
Chronic Kidney Diseases
Registration Number
NCT04809493
Lead Sponsor
University Hospital, Montpellier
Brief Summary

Aim of this study is to evaluate, in a population of chronic kidney disease patients on dialysis (Stage 5D), the effect of treatment with isonatremic dialysis (vs conventional dialysis), during an observational period of 2 months each, on:

* control of interdialytic weight gain

* perdialytic tolerance in terms of adverse events occurring during all of the sessions of the study

* body composition and thirst measured monthly during the 4 months of follow-up.

* tolerance to treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of interdialytic weight gain during treatment1, 2, 3 and 4 months after inclusion

change of interdialytic weight gain during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.

Secondary Outcome Measures
NameTimeMethod
Rate of Tolerance1, 2, 3 and 4 months after inclusion

Rate of Tolerance during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.

Perdialytic tolerance in terms of adverse events occurring1, 2, 3 and 4 months after inclusion

Perdialytic tolerance in terms of adverse events occurring during all sessions of the study with isonatremic dialysis vs conventional dialysis for an observational period of 2 months each one.

Body composition1, 2, 3 and 4 months after inclusion

Body composition monthly during treatment with isonatremic dialysis vs conventional dialysis during an observational period of 2 months each one.

Trial Locations

Locations (1)

Uhmontpellier

🇫🇷

Montpellier, France

Uhmontpellier
🇫🇷Montpellier, France
Jean Paul Cristol, Prof
Contact
4 67 33 83 15
jp-cristol@chu-montpellier.fr
Jean-Yves BOSC, MD
Contact
430 781 868
j.bosc@aidersante.com
Farid SAIDANI, MD
Sub Investigator
Hélène LERAY-MORAGUES, MD
Sub Investigator
Cécile TURC-BARON, MD
Sub Investigator
Thomas BACHELET, MD, PhD
Sub Investigator
Franck LEROY, MD
Sub Investigator
Jean-Sébastien SOUWEINE, MD, PhD
Sub Investigator
Hadia HEBIBI, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.